BioMarin Pharmaceutical Statistics

Total Valuation

BIT:1BMRN has a market cap or net worth of EUR 9.49 billion. The enterprise value is 8.91 billion.

Market Cap	9.49B
Enterprise Value	8.91B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	191.78M
Shares Outstanding	n/a
Shares Change (YoY)	+1.65%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.36M

Valuation Ratios

The trailing PE ratio is 19.58 and the forward PE ratio is 12.57.

PE Ratio	19.58
Forward PE	12.57
PS Ratio	3.48
PB Ratio	1.77
P/TBV Ratio	1.92
P/FCF Ratio	16.43
P/OCF Ratio	14.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.57, with an EV/FCF ratio of 15.43.

EV / Earnings	18.39
EV / Sales	3.50
EV / EBITDA	12.57
EV / EBIT	14.42
EV / FCF	15.43

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.10.

Current Ratio	5.52
Quick Ratio	3.20
Debt / Equity	0.10
Debt / EBITDA	0.73
Debt / FCF	0.96
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 7.12%.

Return on Equity (ROE)	9.64%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	7.12%
Return on Capital Employed (ROCE)	10.98%
Revenue Per Employee	897,878
Profits Per Employee	159,440
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.46

Taxes

In the past 12 months, BIT:1BMRN has paid 139.17 million in taxes.

Income Tax	139.17M
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has decreased by -29.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.58%
50-Day Moving Average	53.93
200-Day Moving Average	62.34
Relative Strength Index (RSI)	35.16
Average Volume (20 Days)	355

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, BIT:1BMRN had revenue of EUR 2.73 billion and earned 484.70 million in profits. Earnings per share was 2.50.

Revenue	2.73B
Gross Profit	2.21B
Operating Income	661.96M
Pretax Income	623.87M
Net Income	484.70M
EBITDA	746.28M
EBIT	661.96M
Earnings Per Share (EPS)	2.50

Full Income Statement

Balance Sheet

The company has 1.18 billion in cash and 556.93 million in debt, giving a net cash position of 620.23 million.

Cash & Cash Equivalents	1.18B
Total Debt	556.93M
Net Cash	620.23M
Net Cash Per Share	n/a
Equity (Book Value)	5.36B
Book Value Per Share	27.95
Working Capital	2.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 647.88 million and capital expenditures -70.40 million, giving a free cash flow of 577.49 million.

Operating Cash Flow	647.88M
Capital Expenditures	-70.40M
Free Cash Flow	577.49M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.01%, with operating and profit margins of 24.25% and 17.76%.

Gross Margin	81.01%
Operating Margin	24.25%
Pretax Margin	22.86%
Profit Margin	17.76%
EBITDA Margin	27.34%
EBIT Margin	24.25%
FCF Margin	21.16%

Dividends & Yields

BIT:1BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.65%
Shareholder Yield	n/a
Earnings Yield	5.11%
FCF Yield	6.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BMRN has an Altman Z-Score of 7.57 and a Piotroski F-Score of 7.

Altman Z-Score	7.57
Piotroski F-Score	7